Evidence map›Paper›PMID 25065914›Full record

ArticleAmerican journal of human genetics2014

The Alu-rich genomic architecture of SPAST predisposes to diverse and functionally distinct disease-associated CNV alleles.

Philip M Boone, Bo Yuan, Ian M Campbell, Jennifer C Scull, Marjorie A Withers, Brett C Baggett, Christine R Beck, Christine J Shaw, Pawel Stankiewicz, Paolo Moretti and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. International journal of molecular sciences · 2024
    Article
  6. A germline chimeric KANK1-DMRT1 transcript derived from a complex structural variant is associated with a congenital heart defect segregating across five generations.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Therapeutic Strategies for MutantBrain sciences · 2021
    Review
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 12 institutions in 4 countries.

Philip M BooneDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Bo YuanDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Ian M CampbellDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Jennifer C ScullMedical Genetics Laboratories, Baylor College of Medicine, Houston, TX 77030, USA.
Marjorie A WithersDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Brett C BaggettDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Christine R BeckDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Christine J ShawDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Pawel StankiewiczDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Medical Genetics Laboratories, Baylor College of Medicine, Houston, TX 77030, USA.
Paolo MorettiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA; Michael E. DeBakey VA Medical Center, Houston, TX 77030, USA.
Wendy E GoodwinChildren's Medical Center of Dallas, Dallas, TX 75207, USA.
Nichole HeinDepartment of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
John K FinkDepartment of Neurology, University of Michigan, Ann Arbor, MI 48109, USA; Geriatrics Research Education and Clinical Center, Ann Arbor, MI 48105, USA; Veterans Affairs Medical Center, Ann Arbor, MI 48015, USA.
Moon-Woo SeongDepartment of Laboratory Medicine, Seoul National University Hospital, Seoul 110-799, Korea.
Soo Hyun SeoDepartment of Laboratory Medicine, Seoul National University Hospital, Seoul 110-799, Korea.
Sung Sup ParkDepartment of Laboratory Medicine, Seoul National University Hospital, Seoul 110-799, Korea.
Izabela D KarbassiQuest Diagnostics, Athena Diagnostics, Worcester, MA 01605, USA.
Sat Dev BatishQuest Diagnostics, Athena Diagnostics, Worcester, MA 01605, USA.
Andrés Ordóñez-UgaldeFundación Pública Galega de Medicina Xenómica-SERGAS, IDIS, CIBERER, Santiago de Compostela 15706, Spain.
Beatriz QuintánsFundación Pública Galega de Medicina Xenómica-SERGAS, IDIS, CIBERER, Santiago de Compostela 15706, Spain.
María-Jesús SobridoFundación Pública Galega de Medicina Xenómica-SERGAS, IDIS, CIBERER, Santiago de Compostela 15706, Spain.
Susanne StemmlerDepartment of Human Genetics, Ruhr University, Bochum 44801, Germany.
James R LupskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Medical Genetics Laboratories, Baylor College of Medicine, Houston, TX 77030, USA; Texas Children's Hospital, Houston, TX 77030, USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: jlupski@bcm.edu.
Baylor College of Medicine · USSeoul National University Hospital · KRFundación Pública Galega de Medicina Xenómica · ESQuest Diagnostics (United States) · USBaylor Genetics · USChildren's Medical Center · USGeriatric Research Education and Clinical Center · USMichael E. DeBakey VA Medical Center · USRuhr University Bochum · DEServicio Gallego de Salud · ESTexas Children's Hospital · USUniversity of Michigan · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007330 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI PLON, SHARON E. · 1985 to 2019
$15.6M
Baylor-Johns Hopkins Center for Mendelian GeneticsU54HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2012 to 2015
$15.6M
Baylor-Johns Hopkins Center for Mendelian GeneticsUM1HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2016 to 2020
$14.5M
Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, NEUL, JEFFREY L · 2014 to 2019
$7.8M
Nonrecurrent rearrangements, genome architecture and neurodegenerative disease.R01NS058529 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI LUPSKI, JAMES R. · 2009 to 2017
$5.0M
Mutidisciplinary Training;Brain Disorders &DevelopmentT32NS043124 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI SWANN, JOHN WILLIAM · 2002 to 2021
$4.6M
New Insights into Motor Neuron DiseaseR01NS069700 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FINK, JOHN K. · 2011 to 2014
$1.3M
Genomic Disorders in Neurodevelopmental DiseaseF31NS083159 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI CAMPBELL, IAN MORGAN · 2013 to 2014
$67k
NOVEL INSIGHTS INTO MOTOR NEURON DISEASEI01CX000344 · VA · VETERANS HEALTH ADMINISTRATION · PI FINK, JOHN K. · 2011 to 2013
–
CSRD VA I01 CX000344NHGRI NIH HHS U54 HG006542NHGRI NIH HHS U54HG006542NHGRI NIH HHS UM1 HG006542NICHD NIH HHS U54 HD083092NIGMS NIH HHS T32 GM007330NIGMS NIH HHS T32GM007330NINDS NIH HHS F31 NS083159NINDS NIH HHS R01 NS058529NINDS NIH HHS R01NS058529NINDS NIH HHS R01NS0679700NINDS NIH HHS R01 NS069700NINDS NIH HHS T32 NS043124
6 · The paper itself

Abstract

Intragenic copy-number variants (CNVs) contribute to the allelic spectrum of both Mendelian and complex disorders. Although pathogenic deletions and duplications in SPAST (mutations in which cause autosomal-dominant spastic paraplegia 4 [SPG4]) have been described, their origins and molecular consequences remain obscure. We mapped breakpoint junctions of 54 SPAST CNVs at nucleotide resolution. Diverse combinations of exons are deleted or duplicated, highlighting the importance of particular exons for spastin function. Of the 54 CNVs, 38 (70%) appear to be mediated by an Alu-based mechanism, suggesting that the Alu-rich genomic architecture of SPAST renders this locus susceptible to various genome rearrangements. Analysis of breakpoint Alus further informs a model of Alu-mediated CNV formation characterized by small CNV size and potential involvement of mechanisms other than homologous recombination. Twelve deletions (22%) overlap part of SPAST and a portion of a nearby, directly oriented gene, predicting novel chimeric genes in these subjects' genomes. cDNA from a subject with a SPAST final exon deletion contained multiple SPAST:SLC30A6 fusion transcripts, indicating that SPAST CNVs can have transcriptional effects beyond the gene itself. SLC30A6 has been implicated in Alzheimer disease, so these fusion gene data could explain a report of spastic paraplegia and dementia cosegregating in a family with deletion of the final exon of SPAST. Our findings provide evidence that the Alu genomic architecture of SPAST predisposes to diverse CNV alleles with distinct transcriptional--and possibly phenotypic--consequences. Moreover, we provide further mechanistic insights into Alu-mediated copy-number change that are extendable to other loci.

Indexed as

Adenosine TriphosphatasesAlu ElementsBase SequenceCation Transport ProteinsCell Line, TransformedDNA Copy Number VariationsGenotypeHumansProtein IsoformsRecombinant Fusion ProteinsSequence Analysis, DNASequence DeletionSpastic Paraplegia, HereditarySpastinAdenosine TriphosphatasesCation Transport ProteinsProtein IsoformsRecombinant Fusion ProteinsSLC30A6 protein, humanSpastinSPAST protein, human

Identifiers

PMID25065914
PMCPMC4129405
OpenAlexW1988878096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.